The use of insulin degludec and insulin glargine results in better glycemic control with reduced HbA1c and improved time in range, and lower insulin daily dose than NPH insulin among toddlers and preschoolers with T1D. This evidence concerns the gene INS and type 1 diabetes mellitus.